Category: Advisories

March 30, 2020 FDA ISSUES “CONDUCT OF CLINICAL TRIALS OF MEDICAL PRODUCTS DURING COVID-19 PANDEMIC” On March 27, 2020, the U.S. Food and Drug Administration (FDA) issued an updated guidance… Read more »

March 25, 2020 Late yesterday, the United States Department of Labor (DOL) issued its first guidance on the Families First Coronavirus Response Act (FFCRA or the Act), including a few… Read more »

March 25, 2020 Federal agencies are taking action to help prevent the public from scammers and fraudsters trying to profit from people’s fears and vulnerabilities regarding the coronavirus crisis. Sadly,… Read more »

March 25, 2020 Amid the developments related to COVID-19, many Virginia hospitals are seeking guidance on how to  accommodate a surge of patients while staying in compliance with hospital licensure… Read more »

March 19, 2020 CMS released guidance on limiting all elective surgeries and non-essential adult medical, surgical and dental procedures in order to conserve critical healthcare resources such as ventilators and… Read more »

March 17, 2020 On March 13, 2020, the Centers for Medicare and Medicaid Services (CMS) updated its Quality, Safety & Oversight memorandum (the “Memorandum”) addressing guidelines for Infection Control and… Read more »

March 16, 2020 BOARD OF PHARMACY UPDATES Pursuant to Chapter 3.2 (§ 44-146.13 et seq.) of Title 44, the Virginia Board of Pharmacy (the “Board”) issued its current position on… Read more »

March 16, 2020 On March 14, 2020, the United States House of Representatives passed House Resolution 6201, the Families First Coronavirus Response Act (the “Act’).  While this legislation guarantees free… Read more »

March 13, 2020 In the event of a disaster or emergency, like the COVID-19 pandemic, Section 1135 of the Social Security Act (the “Act”) allows for the waiver of certain… Read more »